Zydus Lifesciences (BOM:532321) Construction In Progress : ₹0 Mil (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Zydus Lifesciences Construction In Progress?

Zydus Lifesciences's quarterly construction in progress increased from Jun. 2023 (₹0 Mil) to Sep. 2023 (₹12,200 Mil) but then declined from Sep. 2023 (₹12,200 Mil) to Dec. 2023 (₹0 Mil).

Zydus Lifesciences's annual construction in progress declined from Mar. 2021 (₹7,832 Mil) to Mar. 2022 (₹6,610 Mil) but then increased from Mar. 2022 (₹6,610 Mil) to Mar. 2023 (₹11,302 Mil).

Zydus Lifesciences Construction In Progress Historical Data

The historical data trend for Zydus Lifesciences's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zydus Lifesciences Construction In Progress Chart

Zydus Lifesciences Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Construction In Progress

Get a 7-Day Free Trial

8,372.00

7,415.00

7,832.00

6,610.00

11,302.00

Zydus Lifesciences Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Construction In Progress	Get a 7-Day Free Trial															-	11,302.00	-	12,200.00	-

Zydus Lifesciences Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Zydus Lifesciences (BOM:532321) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zydus Lifesciences Ltd (BOM:532321) » Definitions » Construction In Progress

Traded in Other Exchanges

ZYDUSLIFE:India

Address

Scheme No. 63, Sarkhej-Gandhinagar Highway, Zydus Corporate Park, Survey No. 536, Near Vaishnodevi Circle, Khoraj (Gandhinagar), Ahmedabad, GJ, IND, 382481

Website

https://www.zyduslife.com

Zydus Lifesciences Ltd is a specialty and generic drug manufacturing company. The product portfolio of the group includes Active Pharmaceutical Ingredients, human formulations, Health and wellness, and Animal health and veterinary products. Its product brands include Aten, Falcigo, Nucoxia, Levoday, Metscore and Arzep among others. It has two segments Pharmaceuticals and Consumer Products. It generates majority of its revenue from the Pharmaceutical segment.

Zydus Lifesciences (BOM:532321) Headlines

No Headlines